Decheng Capital LLC Nuvation Bio Inc. Put Options Transaction History
Decheng Capital LLC
- $356 Billion
- Q1 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding NUVB
# of Institutions
164Shares Held
153MCall Options Held
4.6KPut Options Held
154K-
Black Rock Inc. New York, NY16.2MShares$36.4 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA15.4MShares$34.5 Million0.0% of portfolio
-
Omega Fund Management, LLC Boston, MA13.1MShares$29.3 Million47.43% of portfolio
-
Laurion Capital Management LP New York, NY9.87MShares$22.1 Million0.45% of portfolio
-
Octagon Capital Advisors LP New York, NY7.9MShares$17.7 Million4.63% of portfolio
About Nuvation Bio Inc.
- Ticker NUVB
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 217,244,000
- Market Cap $487M
- Description
- Nuvation Bio Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutic candidates for oncology. The company's lead product candidate is NUV-422, a small molecule inhibitor targeting cyclin-dependent kinase (CDK)2, CDK4, and CDK6. It is also developing NUV-868, a selective oral small molecule BET inhibitor that e...